VALENTA PHARM, PAO ,   Russia

Tablets, coated with enteric coating, 1 g.

Tablets, film-coated, 5 mg.

tablets, film-coated 25 mg, 50 mg and 100 mg

Solution for intravenous and intramuscular injection 25 mg / ml.

Dragee 25 mg, 50 mg and 100 mg.

Tablets 10 mg.

Tablets of 250 mg.

Tablets effervescent [orange and lemon, forest berries] 500 mg + 10 mg + 100 mg.

Tablets, 1 mg.

Tablets of prolonged action, film-coated, 4 mg.

Dragee 50 mg.

Pills.

Intestine-soluble film coated tablets, 300 mg.

Tablets, coated with enteric coating, 50 mg.

Tablets 500 mg + 50 mg.

Tablets of 50 mg and 100 mg.

Tablets of 200 mg.

Tablets, film-coated, 40 mg and 80 mg.

Pills.

Dragee.

Tablets for resorption, 1.5 mg.

Spray dosed for topical use of 0.06 mg + 0.1 mg / dose.

Tablets of 50 mg and 100 mg.

Solution for infusion and external use 5 mg / ml.

Capsules 500 mg.

Capsules 60 mg.

Tablets, film-coated, 2.5 mg.

Tablets of 25 mg and 50 mg.

Tablets 200 mg.

Solution for intravenous administration 50 mg / ml.

Tablets 200 mg.

Tablets 25 mg and 100 mg.

Film-coated tablets.

Tablets, film-coated, 400 mg.

Tablets 10 mg.

Capsules 20 mg.

The tablets covered with a cover, on 200 mg.

Tablets, covered with enteric coating.

Tablets 500 mg.

The tablets covered with a cover.

Tablets of prolonged action, film-coated, 400 mg.

For 10 tablets in a contour mesh box made of polyvinylchloride film and aluminum foil printed lacquered. For 30 or 60 tablets in cans of polymeric. Each jar, 3 or 6 contour squares together with instructions for use in a pack of cardboard.

Tablets coated with enteric coating 100 mg. For 10 tablets in a planar cell package. For 30 or 60 tablets in glass or plastic jars.

Each jar, 3 or 6 contour squares is placed together with the instructions for use in a pack of cardboard.

Intestine-soluble film coated tablets, 100 mg.

For 10 tablets in a contour mesh box made of polyvinylchloride film and aluminum foil printed lacquered.

6 contour mesh packages together with instructions for use are placed in a pack of cardboard.

Film-coated tablets.

Tablets, 10 mg and 20 mg.

Tablets, film-coated, 150 mg. For 10 tablets in a contour mesh box made of polyvinylchloride film and aluminum foil printed lacquered. 2 contour mesh packs together with instructions for use are placed in a pack of cardboard.

Capsules 150 mg.

Capsules 250 mg.

Capsules 300 mg.

Capsules 250 mg + 10 mg.

Capsules 300 mg + 10 mg.

Tablets, film-coated, 200 mg.

Capsules, 100 mg.

Tablets, film-coated 10 mg, 20 mg and 40 mg.

By 10 tablets into a contour mesh box made of polyvinyl chloride film and aluminum foil printed lacquered.

3 contour packagings along with the toolksieth nabout primyenMr.andyu pomconsciencein pachku from cardboard.

Tablets 10 mg and 20 mg.

For 10 tablets in a planar cell packaging made of polyvinylchloride film and aluminum foil printed lacquered.

For 100 tablets with a dosage of 10 mg in polymer cans complete with lids.

Each jar, 3 contiguous cell packs with tablets of 20 mg or. . 10 contour cell packs with 10 mg tablets together with instructions for use in a pack of cardboard.

Tablets of prolonged action of 100 mg, 200 mg and 300 mg.

For 10 tablets in a contour mesh box made of polyvinylchloride film and aluminum foil printed lacquered.

Solution for infusion and intramuscular injection, 5 mg / ml.

Tablets of 100 mg and 200 mg.

Tablets, film-coated, 20 mg.

Tablets with modified release, film-coated, 35 mg.

Tablets, film-coated, 14 mg.

Tablets 0.5 mg, 1 mg and 2.5 mg.

Solution for intravenous and intramuscular injection 1 mg / ml.

Film-coated tablets, 250 and 500 mg.

Capsules 250 mg + 10 mg.

Capsules 250 mg.

Tablets, film-coated 250 mg.

Tablets, film-coated 500 mg.

Tablets 10 mg.

Tablets 5 mg and 20 mg.

Film coated tablets, 25 mg and 100 mg.